Literature DB >> 15304981

Design and evaluation of cyclodextrin-based drug formulation.

Kaneto Uekama1.   

Abstract

The pharmaceutically useful cyclodextrins (CyDs) are classified into hydrophilic, hydrophobic, and ionic derivatives. Because of the multi-functional characteristics and bioadaptability, these CyDs are capable of alleviating the undesirable properties of drug molecules through the formation of inclusion complexes or the form of CyD/drug conjugates. This review outlines the current application of CyDs in design and evaluation of CyD-based drug formulation, focusing on their ability to enhance the drug absorption across biological barriers, the ability to control the rate and time profiles of drug release, and the ability to deliver a drug to a targeted site.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15304981     DOI: 10.1248/cpb.52.900

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  31 in total

1.  New cyclodextrin hydrogels cross-linked with diglycidylethers with a high drug loading and controlled release ability.

Authors:  Carmen Rodriguez-Tenreiro; Carmen Alvarez-Lorenzo; Ana Rodriguez-Perez; Angel Concheiro; Juan J Torres-Labandeira
Journal:  Pharm Res       Date:  2006-12-07       Impact factor: 4.200

2.  New fluorogenic probes for neutral and alkaline ceramidases.

Authors:  Mireia Casasampere; Núria Bielsa; Daniel Riba; Laura Bassas; Ruijuan Xu; Cungui Mao; Gemma Fabriàs; José-Luis Abad; Antonio Delgado; Josefina Casas
Journal:  J Lipid Res       Date:  2019-03-29       Impact factor: 5.922

Review 3.  Obstructing toxin pathways by targeted pore blockage.

Authors:  Ekaterina M Nestorovich; Sergey M Bezrukov
Journal:  Chem Rev       Date:  2012-10-11       Impact factor: 60.622

Review 4.  Advanced technologies for oral controlled release: cyclodextrins for oral controlled release.

Authors:  Paulo José Salústio; Patrícia Pontes; Claúdia Conduto; Inês Sanches; Catarina Carvalho; João Arrais; Helena M Cabral Marques
Journal:  AAPS PharmSciTech       Date:  2011-09-27       Impact factor: 3.246

5.  Oral bioavailability of a poorly aqueous drug from three different SBE7-β-cyclodextrin based formulations in beagle dogs.

Authors:  René Holm; Lene Andresen; Claus Strange
Journal:  Results Pharma Sci       Date:  2011-10-08

6.  Complex of branched cyclodextrin and lidocaine prolonged the duration of peripheral nerve block.

Authors:  Ryoko Suzuki; Young-Chang P Arai; Kenichi Hamayasu; Koki Fujita; Kozo Hara; Tokio Yamaguchi; Shiro Sasaguri
Journal:  J Anesth       Date:  2009-05-15       Impact factor: 2.078

7.  Difluorobenzocyclooctyne: synthesis, reactivity, and stabilization by beta-cyclodextrin.

Authors:  Ellen M Sletten; Hitomi Nakamura; John C Jewett; Carolyn R Bertozzi
Journal:  J Am Chem Soc       Date:  2010-08-25       Impact factor: 15.419

8.  Effect of cyclodextrin complexation on the aqueous solubility and solubility/dose ratio of praziquantel.

Authors:  Stratos Maragos; Helen Archontaki; Panos Macheras; Georgia Valsami
Journal:  AAPS PharmSciTech       Date:  2009-12-01       Impact factor: 3.246

Review 9.  Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies.

Authors:  Raphael Zidovetzki; Irena Levitan
Journal:  Biochim Biophys Acta       Date:  2007-04-06

Review 10.  Opportunities for targeting the angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor pathway in hypertension.

Authors:  Rodrigo Araujo Fraga-Silva; Anderson Jose Ferreira; Robson Augusto Souza Dos Santos
Journal:  Curr Hypertens Rep       Date:  2013-02       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.